Skip to main content
Clinical Trials/NCT05038579
NCT05038579CompletedNot Applicable

Clinical Validation of a Cognitive Stimulation Platform for Individuals With Dementia - Musiquence

Universidade da Madeira1 site in 1 country13 target enrollmentStarted: September 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
13
Locations
1
Primary Endpoint
Mini-Mental State Examination (Cognitive Screening) (MMSE)

Study Overview

Brief Summary

Dementia is a neurodegenerative syndrome that leads to cognitive deficits and, consequently, affects functionality and quality of life.

This study will explore the clinical impact of a customized cognitive stimulation program, using Musiquence.

Detailed Description

Dementia is a clinical syndrome characterized by a progressive and irreversible deterioration of cognitive functioning that impairs behavioral and functional domains. Within non-pharmacological approaches, Cognitive Stimulation Therapy (CST) is the most studied and well-established intervention for individuals with mild to moderate dementia. The underlying assumptions behind cognitive-based interventions of CST are:

  1. IwD can benefit from cognitive stimulation if mobilized relatively preserved cognitive functions (e.g., crystallized abilities such as semantic memory and verbal skills), and;
  2. Even in advanced age, exposure to enriched environments (i.e., socially and cognitively challenging) can enhance cognitive reserve and neuroplasticity.

Concerning the first assumption of cognitive-based interventions (a1), it is known that even in moderate to advanced stages of dementia, musical memory is one of the abilities that remain intact. It is hypothesized that music processing abilities precede the development of lexical language functions. This hypothesis is corroborated by findings that demonstrate that IwD are still responsive to music even when unable to communicate verbally or recognize words. Additionally, music is frequently associated with life experiences. Also, literature has reported that memories associated with specific music would be recollected longer than memories with no association to music; this suggests that using music as a reminiscence element on cognitive stimulation programs can have a promising effect on cognition. According to the second assumption of CST (a2), facilitating an enriching environment for IwD using, for , music and reminiscence elements could impact cognitive reserve and neuroplasticity.

In this context, Ferreira et al. developed a platform - Musiquence - that incorporates music and reminiscence in cognitive stimulation activities for IwD. Musiquence allows the gamification and personalization of 6 types of activities:

  • Reality Orientation - a quiz-like activity that includes date and time information.
  • Creative Drawings - a puzzle-like game in which the participant draws the missing pieces.
  • Activities of Daily Living (ADL) - a puzzle-like game in which the participants have to perform a set of chores (i.e., brush the teeth), and the missing pieces are completed with real physical objects (i.e., toothpaste).
  • Search Objects activity - exploration game in which the participants must find hidden images (e.g., cats) that are only visible through a virtual magnifying glass.
  • Knowledge Quiz - participants must select the correct answer to a question among incorrect ones.
  • Association activity - participants must categorize the items according to the instructions. For example, separate cars from motorcycles and locate them in the correct container.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Mild to moderate stage of dementia (with formal diagnosis);
  • •Ability to move upper limbs;
  • •Maintained auditory acuity;
  • •Relatively preserved language skills.

Exclusion Criteria

  • •Moderate to severe depressive symptomatology;
  • •Moderate to severe anxious symptomatology;
  • •Bedridden.

Arms & Interventions

Musiquence

Experimental

Dementia group was involved in a 14-session customized cognitive stimulation program, using Musiquence.

Intervention: Musiquence (Procedure)

Outcomes

Primary Outcomes

Mini-Mental State Examination (Cognitive Screening) (MMSE)

Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)

Change from baseline in the MMSE. Minimum of 0 points and maximum of 30 points. Higher scores mean better outcomes.

Alzheimer's Disease Assessment Scale - Cognitive Scale (ADAS - Cog)

Time Frame: Baseline, Post-intervention (7 weeks), Follow-up (3 months)

Change from baseline in the ADAS-Cog. Minimum of 0 points and maximum of 68 points. Higher scores mean worse outcomes.

Secondary Outcomes

  • Quality of Life - Alzheimer's Disease (QoL - AD)(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Kettler Laurent Thierreau (KLT)(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Symbol Search - Weschler Adult Inteligence Scale 3rd edition (SR)(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Rating Anxiety in Dementia (RAID) scale.(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Semantic and Phonemic Verbal Fluency (SPVF)(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Digital Symbol Coding - Weschler Adult Inteligence Scale 3rd edition (DSC)(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Cornell Scale for Depression in Dementia(Baseline, Post-intervention (7 weeks), Follow-up (3 months))
  • Adults and Older Adults Functional Assessment Inventory (IAFAI)(Baseline, Post-intervention (7 weeks), Follow-up (3 months))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sergi Bermúdez i Badia

Associate Professor at the University of Madeira and Senior Researcher at NOVA-LINCS

Universidade da Madeira

Study Sites (1)

Loading locations...

Similar Trials

Clinical Validation of a Cognitive... | Clinical Trial